Drug Trial Radar · NCT06876649
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Last checked: Nov 19, 2026Latest source record: Mar 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
787
Planned (sponsor's estimate)
Start
May 20, 2025
Primary completion
May 2030
Study completion Dec 2032
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Mar 14, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of the long-term safety and efficacy of pirtobrutinib after completion of clinical studies evaluating pirtobrutinib. The clinical studies that will feed into this master protocol are referred to as originator studies. The master protocol will govern individual study-specific appendices (ISAs) that will represent participants from the individual, completed originator studies. These participants will have the opportunity to enter this study and continue to receive treatment or continue follow-up visits. Overall, the master protocol and the individual ISAs, when combined, define the investigations for this study.
Conditions
- Chronic Lymphocytic Leukemia
- Non-Hodgkin Lymphoma
Interventions
PirtobrutinibDrug
Administered orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants with a Grade ≥3 treatment-emergent AEsTime frame: Time from the Date of the First Dose of Study Intervention (Study Day 1) through 30 Days (+ 7-day window) After the Date of the Last Dose of Study Intervention or The First Date Starting a New Anticancer Therapy, whichever is Earlier
Locations
38 sites in 8 countries. Site status is shown where the registry gives one.
Cancer Specialists, LLC
Jacksonville, Florida · Not yet recruiting
Sylvester Comprehensive Cancer Center
Miami, Florida · Recruiting
Florida Cancer Specialists
Sarasota, Florida · Recruiting
The Emory Clinic
Atlanta, Georgia · Not yet recruiting
Northwestern University
Chicago, Illinois · Not yet recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts · Recruiting
Mayo Clinic- Minnesota
Rochester, Minnesota · Recruiting
University Of Nebraska Medical Center
Omaha, Nebraska · Recruiting
Cayuga Cancer Center
Ithaca, New York · Recruiting
Northwell Health
Lake Success, New York · Recruiting
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York
New York, New York · Recruiting
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York
New York, New York · Not yet recruiting
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York
New York, New York · Not yet recruiting
Duke University Medical Center
Durham, North Carolina · Recruiting
Ohio State University Comprehensive Cancer Center
Columbus, Ohio · Recruiting
University of Pennsylvania Hospital
Philadelphia, Pennsylvania · Recruiting
Tennessee Oncology
Nashville, Tennessee · Recruiting
University of Texas MD Anderson Cancer Center
Houston, Texas · Recruiting
Swedish Cancer Institute
Seattle, Washington · Recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin · Recruiting
Flinders Medical Centre
Adelaide, Australia · Recruiting
Peter MacCallum Cancer Centre
Melbourne, Australia · Recruiting
Linear Clinical Research
Victoria, Australia · Recruiting
CHU de Nantes - Hotel Dieu
Nantes, France · Recruiting
IRCCS-AOU di Bologna-Policlinico S.Orsola-Malpighi
Bologna, Italy · Recruiting
Ospedale San Raffaele
Milan, Italy · Recruiting
Nagoya Medical Center
Aichi-Ken, Japan · Recruiting
National Cancer Center Hospital
Cho-ku, Japan · Recruiting
National Hospital Organization Kyushu Cancer Center
Fukuoka, Japan · Recruiting
Tokai University Hospital- Isehara Campus
Isehara, Japan · Recruiting
Tohoku University Hospital
Miyagi-Ken, Japan · Recruiting
Hokkaido University Hospital
Sapporo, Japan · Recruiting
Pratia MCM Krakow
Krakow, Poland · Recruiting
Instytut Hermatologii I Transfuzjologii
Warsaw, Poland · Recruiting
Seoul National University Hospital
Seoul, South Korea · Recruiting
St James's University Hospital
Leeds, United Kingdom · Recruiting
Churchill Hospital
Oxford, United Kingdom · Not yet recruiting
Derriford Hospital
Plymouth, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.